相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A facile and universal method to achieve liposomal remote loading of non-ionizable drugs with outstanding safety profiles and therapeutic effect
Shuang Zhou et al.
ACTA PHARMACEUTICA SINICA B (2021)
Bispecific antibodies poised to deliver wave of cancer therapies
Cormac Sheridan
NATURE BIOTECHNOLOGY (2021)
Targeting cancer with bispecific antibodies Bispecific antibodies might provide off-the-shelf immunotherapeutics for treating cancer
Jon Weidanz
SCIENCE (2021)
Effect of physicochemical properties on in vivo fate of nanoparticle-based cancer immunotherapies
Yongchao Wang et al.
ACTA PHARMACEUTICA SINICA B (2021)
Self-assembled ternary hybrid nanodrugs for overcoming tumor resistance and metastasis
Xu Cheng et al.
ACTA PHARMACEUTICA SINICA B (2021)
Influencing factors and strategies of enhancing nanoparticles into tumors in vivo
Mingming Zhang et al.
ACTA PHARMACEUTICA SINICA B (2021)
From Design to Clinic: Engineered Nanobiomaterials for Immune Normalization Therapy of Cancer
Madiha Saeed et al.
ADVANCED MATERIALS (2021)
Engineering Stimuli-Activatable Boolean Logic Prodrug Nanoparticles for Combination Cancer Immunotherapy
Bo Hou et al.
ADVANCED MATERIALS (2020)
Dynamic covalent chemistry-regulated stimuli-activatable drug delivery systems for improved cancer therapy
Qiwen Zhu et al.
CHINESE CHEMICAL LETTERS (2020)
Sheddable Prodrug Vesicles Combating Adaptive Immune Resistance for Improved Photodynamic Immunotherapy of Cancer
Ang Gao et al.
NANO LETTERS (2020)
Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy
Jing Gao et al.
ACTA PHARMACOLOGICA SINICA (2020)
Remote loading paclitaxel-doxorubicin prodrug into liposomes for cancer combination therapy
Jiang Yu et al.
ACTA PHARMACEUTICA SINICA B (2020)
Engineering Prodrug Nanomedicine for Cancer Immunotherapy
Bin Yang et al.
ADVANCED SCIENCE (2020)
Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn-AhR-AQP4 signaling pathway
Lisha Du et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy
Qianmei Yang et al.
THERANOSTICS (2020)
Tumour-intrinsic resistance to immune checkpoint blockade
Anusha Kalbasi et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Bispecific antibodies: a mechanistic review of the pipeline
Aran F. Labrijn et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Redox-sensitive prodrug nanoassemblies based on linoleic acid-modified docetaxel to resist breast cancers
Meng Li et al.
ACTA PHARMACEUTICA SINICA B (2019)
Cancer immunoediting and resistance to T cell-based immunotherapy
Jake S. O'Donnell et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Photosensitizer Micelles Together with IDO Inhibitor Enhance Cancer Photothermal Therapy and Immunotherapy
Jinrong Peng et al.
ADVANCED SCIENCE (2018)
Acidity-Triggered Ligand-Presenting Nanoparticles To Overcome Sequential Drug Delivery Barriers to Tumors
Tingting Wang et al.
NANO LETTERS (2017)
Kynurenines: Tryptophan's metabolites in exercise, inflammation, and mental health
Igor Cervenka et al.
SCIENCE (2017)
Small molecule nanodrugs for cancer therapy
Yuan Ma et al.
MATERIALS TODAY CHEMISTRY (2017)
Cancer nanomedicine: progress, challenges and opportunities
Jinjun Shi et al.
NATURE REVIEWS CANCER (2017)
Interferon-γ Drives Treg Fragility to Promote Anti-tumor Immunity
Abigail E. Overacre-Delgoffe et al.
CELL (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression
Hengrui Zhu et al.
CELL REPORTS (2016)
Acquired resistance to immunotherapy and future challenges
Nicholas P. Restifo et al.
NATURE REVIEWS CANCER (2016)
IDO inhibitors move center stage in immuno-oncology
Cormac Sheridan
NATURE BIOTECHNOLOGY (2015)
Cancer nanomedicine: from targeted delivery to combination therapy
Xiaoyang Xu et al.
TRENDS IN MOLECULAR MEDICINE (2015)
Adaptive Immune Resistance: How Cancer Protects from Immune Attack
Antoni Ribas
CANCER DISCOVERY (2015)
Disulfide Bond Bridge Insertion Turns Hydrophobic Anticancer Prodrugs into Self-Assembled Nanomedicines
Yongjun Wang et al.
NANO LETTERS (2014)
Targeting bromodomains: epigenetic readers of lysine acetylation
Panagis Filippakopoulos et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells
Stefani Spranger et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Challenges in design of translational nanocarriers
Qihang Sun et al.
JOURNAL OF CONTROLLED RELEASE (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Therapeutic antibodies for autoimmunity and inflammation
Andrew C. Chan et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Calreticulin exposure dictates the immunogenicity of cancer cell death
Michel Obeid et al.
NATURE MEDICINE (2007)
Photodynamic therapy and anti-tumour immunity
Ana P. Castano et al.
NATURE REVIEWS CANCER (2006)
IDO and tolerance to tumors
DH Munn et al.
TRENDS IN MOLECULAR MEDICINE (2004)
Tryptophan catabolism and regulation of adaptive immunity
AL Mellor et al.
JOURNAL OF IMMUNOLOGY (2003)
分享论文
